Printer Friendly

Browse Angiogenesis inhibitors topic

Articles

1-300 out of 528 article(s) nextnext page
Title Author Type Date Words
Starton Successfully Completes Proof of Concept Study for Transdermal Lenalidomide. Dec 27, 2019 853
Medicinal Products Containing Everolimus Ii. Nov 22, 2019 127
Janssen Receives EU Marketing Authorisation for Darzalex in Combination with Lenalidomide and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible. Nov 21, 2019 601
Provision Of Medicinal Products Containing Everolimus Ii. Nov 20, 2019 135
Conclusion Of A Non-exclusive Discount Contract Pursuant To 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc Code: L01xe10). Nov 19, 2019 462
Framework Agreement For Drug Supply Paclitaxel (abraxane) - Lenalidomide (revlimid). Nov 19, 2019 116
Lenalidomide Delays Progression in Smoldering Multiple Myeloma; Progression-free survival significantly longer with lenalidomide compared with observation. Nov 7, 2019 282
Antineoplastics With The Active Substance Everolimus. Oct 31, 2019 102
Open House Discounts 2019-19 - Everolimus. Oct 23, 2019 262
Roche's Tecentriq In Combination With Avastin Improves Survival. Oct 21, 2019 199
Genentech says Phase III IMbrave150 study met co-primary endpoints. Oct 21, 2019 226
Completion Of Indication-limited Non-exclusive Discount Agreements Pursuant To 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc: L01xe10) - Patent-free Indications - Open-house Model. Oct 16, 2019 454
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On Finished Medicinal Products Containing The Active Ingredient Everolimus, Atc L01xe10 - Here: Indication Breast Cancer. Sep 24, 2019 357
Medicinal Products Containing Everolimus. Sep 18, 2019 124
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On Finished Medicinal Products Containing The Active Ingredient Everolimus, Atc L01xe10, Patent-free Indication. Sep 18, 2019 386
Supply Of Medicinal Products Containing Everolimus. Sep 17, 2019 193
Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Everolimus (only Indication Gi Net), Atc L01xe10, For The Period 1.11.2019 - 31.10.2021. Sep 17, 2019 240
Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Everolimus (exclusively Breast Cancer Indication), Atc L01xe10, For The Period 1.11.2019 - 31.10.2021. Sep 17, 2019 512
Medicinal Products Containing The Active Substance Pazopanib. Aug 25, 2019 125
China Recombinant Human Endostatin Investigation Market Report, 2019-2023. Report Aug 23, 2019 589
Provision Of Medicinal Products Containing Pazopanib. Aug 22, 2019 189
Supply Of Reagents, Fungible Material And Assignment Of Equipment To Perform The Determinations Of Everolimus, Mycophenolate, Topiramate, Buprenorphine And Ethylglucuronide In The Clinical Analysis Laboratory Of The University Hospital Are Spases. Aug 16, 2019 132
Corrigendum to "Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features". Correction notice Aug 1, 2019 158
Fragmin Inj 10x0,2ml/5000 Iu. Jul 25, 2019 110
Fragmin Inj 1x10 Ml/10000 Iu. Jul 25, 2019 110
Sunitinib Malate Market Research Report Overview, Scope, Top Manufacturers, and Forecast to 2025. Report Jul 23, 2019 892
Supply Of Drugs For 2019: Pazopanib For Medical Use In Favor Of Citizens For The Purpose Of Their Social Security At The Expense Of The Budget Of The Astrakhan Region. Jul 20, 2019 133
Supply Of Kits For Immunosuppressive Assays In The Blood (ciclosporin, Tacrolimus, Everolimus, Sirolimus) In Lc-ms/Ms Technique For The Pharmacotoxicology Laboratory Of The University Hospital Of Caen. Jul 13, 2019 170
Do Not Ban Avastin, An Intraocular Injection -OSN. Jul 11, 2019 593
Avastin Vial 100 Mg And Avastin Vial 400 Mg (spain-alcal De Henares: Antineoplastic Agents). Jul 11, 2019 117
Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc Code: L01xe10) - Patent-free Indications - As Part Of A. Jul 5, 2019 146
Johnson & Johnson (NYSE: JNJ) - Janssen Announces U.S. FDA Approval of DARZALEX[R] (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible -- 27/6/2019. Jul 4, 2019 492
Delivery Of Medicinal Products By Atc Group L04ax04 - Lenalidomide For Hospitals Cesk Budejovice, As. Jul 1, 2019 113
Preparation and Evaluation of Inflammation Targeted Nano-micellar Formulation of Celecoxib. Bahadori, Fatemeh; Buyuk, Ayse Smyrna; Kozanoglu, Ahmed Serdar; Eskandari, Zahra; Ankarali, Handan; Jul 1, 2019 4256
United States : Janssen Announces U.S. FDA Approval of DARZALEX (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible. Jun 29, 2019 562
Drug Delivery - Avastin - L01xc07 (czechia-prague: Antineoplastic Agents). Jun 14, 2019 124
Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc Code: L01xe10) - Patent-free Indications - As Part Of A. May 31, 2019 150
Celgene Corporation (NASDAQ: CELG) - FDA Approves REV LI MID[R] (Lenalidomide) In Combination With Rituximab For the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma -- 28/5/2019. May 29, 2019 622
US Food and Drug Administration grants approval to Pfizer's Fragmin injection. May 20, 2019 189
US Food and Drug Administration grants approval to Pfizer's Fragmin injection. May 20, 2019 185
United States : FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots. May 17, 2019 805
Procurement Of Everolimus Eluting Balloon Mounted Platinumn Chromium Stent System. Apr 13, 2019 150
Supply of Everolimus 0.75 Mg Tab. Apr 9, 2019 150
Drug Delivery - Avastin - L01xc07. Apr 3, 2019 157
8201n001-tab. Everolimus 0.25 Mg. In Strip Packing. Firm~s Offer: Brand As Accepted: Evergraf 0.25. (hsn Code-3004-9099) Mfgd. & Mktd. By M/s. Panacea Biotech Ltd. Apr 1, 2019 102
8201n001-cap. Lenalidomide 5 Mg Brand- Lenangio 5 Mfg In India By :- Naprod Life Science Pvt. Ltd, G-17/1, M.i.d.c., Tarapur, Boisar, Dist.-thane-401506 Marketed By:- Dr. Reddy~s Laboratories Ltd., Gl. Mar 28, 2019 103
Procurement Of Everolimus Eluting Balloon Mounted Platinum Chromium Coronary Stent System. Mar 23, 2019 149
Cancer patient is denied 'vital' drug because she lives wrong side of border. Mar 19, 2019 633
Cancer patient denied 'vital' drug because she lives half a mile wrong side of border. Mar 18, 2019 627
Terminally ill cancer patient denied life-prolonging drug because she lives HALF A MILE over the border; Joannah Houghton, who gets chemotherapy treatment at Clatterbridge Cancer Centre in Wirral, misses out on Avastin by a journey of just three minutes. Mar 17, 2019 749
Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On Finished Medicinal Products With The Active Ingredient Everolimus, Atc L01xe10, Patent-free Indication. Feb 27, 2019 378
Pfizer Receives European Approval for Zirabev, a Biosimilar to Avastin. Feb 21, 2019 250
Pfizer reports European approval for biosimilar to Avastin. Feb 19, 2019 118
Roche says CHMP recommends EU approval of Tecentriq in combination with Avastin. Feb 1, 2019 144
Conclusion Of A Non-exclusive Discount Contract According To 130a Abs. 8 Sgb V On Medicines Containing The Active Ingredient Dalteparin (atc-code: B01ab04). Feb 1, 2019 501
Open House Discounts 2019-04 - Everolimus. Jan 31, 2019 254
Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs.8 Sgb V On The Active Substance Everolimus (patent-free Indications), Atc Code: L04aa18 & L01xe10, For The Period From 1.3.2019 To 28.2.2021. Jan 29, 2019 262
FDA Approves Genentech's Tecentriq in Combination with Avastin and Chemotherapy for the Initial Treatment of People with a Specific Type of Metastatic Lung Cancer. Dec 11, 2018 624
Switzerland : FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer. Dec 10, 2018 282
United States : FDA Approves Genentechs Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of People With a Specific Type of Metastatic Lung Cancer. Dec 10, 2018 290
82028825-(ph No. : 25098) Bevacizumab 100 Mg Inj. Accepted Description Same As Tendered Description. Brand: Cizumab 100. Mfd By M/s.hetero Biopharma Ltd. Mktd By M/s. Hetero Healthcare Ltd. Dec 10, 2018 101
Premature Bebeklerde Retinopati Gelisimine Etki Eden Risk Faktorlerinin Degerlendirilmesi/Evaluation of Risk Factors Affecting Development of Retinopathy in Premature Infants. Gul, Filiz; Bulbul, Ali Report Dec 1, 2018 4483
Bevacizumab 2017 (czech Republic-brno: Antineoplastic Agents). Nov 4, 2018 112
WET AMD DRUG RULING. Brief article Nov 1, 2018 149
Tender For The Supply Of Ilaris, Cosentyx And Votubia, With Negotiated Procedure Without Publication Of A Tender Notice - Dpdddp.p 114/2018. (cyprus-nicosia: Antineoplastic And Immunomodulating Agen. Oct 30, 2018 204
Everolimus (czech Republic-brno: Antineoplastic Agents). Oct 30, 2018 120
Supply Of Exclusive Medicines: Canakinumab, Everolimus, Lapatinib, Nilotinib, Pazopanib, Ruxolitinib, In Its Different Presentations, For All The Centers Affiliated To The Pls De Sevilla. Oct 28, 2018 106
Supply Of Exclusive Medicines: Canakinumab, Everolimus, Lapatinib, Nilotinib, Pazopanib, Ruxolitinib, In Its Different Presentations, For All The Centers Attached To The Pls Of Seville. Oct 28, 2018 104
Application of Lenalidomide on Diffused Large B-cell Lymphoma: Salvage, Maintenance, and Induction Treatment. Ma, Li-Yangxue; Su, Li Report Oct 20, 2018 2492
Supply Of Exclusive Medicines: Dabrafenib, Everolimus, Nilotinib, Ranibizumab, Ruxolitinb. Oct 19, 2018 117
Exclusive Medicines Supply: Bevacizumab 400 Mg, Bevacizumab 100 Mg, Pertuzumab 420 Mg. Oct 16, 2018 118
A PS1.3 million victory for common sense. Oct 4, 2018 703
Supply Of Medicinal Products With The Active Substance Bevacizumab. Sep 29, 2018 183
Health leaders cheer High Court victory for cheaper eye treatment; Case was brought by pharmaceutical giants Bayer and Novartis against 12 CCGs - including Stockton and Hartlepool. Sep 28, 2018 708
Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Dalteparin, Atc B01ab04, For The Period 1.11.2018 - 31.10.2020. Sep 23, 2018 513
NHS legal win in big pharma drugs battle. Sep 22, 2018 118
Leiters to ship new repackaged Avastin under US FDA 2018 guidance. Sep 20, 2018 214
Leiters to ship new repackaged Avastin under US FDA 2018 guidance. Sep 20, 2018 210
Rituximab + Lenalidomide Effective in Follicular Lymphoma; Response rate, progression-free survival comparable to those seen with rituximab-chemotherapy. Sep 11, 2018 248
Cytostatics And Immunomodulators - Bevacizumab. Sep 1, 2018 133
Effects of Two-by-Two Combination Therapy with Valproic Acid, Lithium Chloride, and Celecoxib on the Angiogenesis of the Chicken Chorioallantoic Membrane. Afzal, Ehsan; Alinezhad, Sedigheh; Khorsand, Marjan; Khoshnood, Mohammad Javad; Takhshid, Mohammad A Sep 1, 2018 4220
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer. Aug 31, 2018 476
Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Everolimus (atc: L01xe10) As Part Of A So-called Open-house Model. Aug 3, 2018 493
Supply Of Lenalidomide. Jul 27, 2018 101
Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Dalteparin (atc: B01ab04) Within The Framework Of A So-called Open-house Model. (germany-eisenberg: Pharmaceutical Products). Jul 26, 2018 136
United States : FDA grants Breakthrough Therapy Designation for Roches Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC). Jul 18, 2018 437
United States : FDA Grants Breakthrough Therapy Designation for Genentechs TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC). Jul 18, 2018 492
Genistein Improves Liver Damage in Male Mice Exposed to Morphine. Salahshoor, Mohammad; Roshankhah, Shiva; Hosseni, Payman; Jalili, Cyrus Report Jul 5, 2018 5149
CORRELATION OF INTRAOCULAR PRESSURE WITH OCULAR AXIAL LENGTH AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB IN DIABETIC MACULAR EDEMA. Report Jun 30, 2018 3237
Supply Of Exclusive Medicines Bevacizumab 400 Mg, Bevacizumab 100 Mg, Pertuzumab 420 Mg, Rituximab 1 400 Mg. Jun 28, 2018 114
Fn Motol - Bevacizumab 100 Mg (czech Republic-prague: Antineoplastic Agents). Jun 25, 2018 116
Roche receives USFDA approval for Avastin. Jun 15, 2018 136
Roche receives USFDA approval for Avastin. Jun 15, 2018 132
Genentech says FDA approves Avastin plus chemotherapy in ovarian cancer. Jun 13, 2018 262
FDA approves Genentech's Avastin plus chemo for ovarian cancer treatment. Jun 13, 2018 152
Eveolimus; No. -08131-18 Delivery Of Everolimus Medicinal Product. Jun 10, 2018 136
Supply Of Medicine Tab Lenalidomide 25mg. Jun 6, 2018 151
Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study/Tuberoskleroz ile Iliskili, Tedaviye Direncli Fokal Baslangicli Nobetler icin Yardimci Everolimus Tedavisi: 3 Asamali, Randomize, Cift Kor, Plasebo Kontrollu Calisma. Karaoglan, Mustafa Report Jun 1, 2018 784
Request No. 7271/208, Everolimus, Compressed 0.25 Mg, Code Igss 10513. May 25, 2018 102
Request No. 7272/208, Everolimus, Compressed 0.25 Mg, Code Igss 10513. May 25, 2018 102
Switzerland : Phase III IMpower150 study showed Roches Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel. May 18, 2018 480
Bevacizumab; Delivery Of Medicinal Products (bevacizumab) To Provide Citizens Of The Russian Federation Who Are On The Territory Of The Republic Of Tatarstan And Who Have The Right To Receive State Social Assistance In Accordance With The Federal Law Of J. May 13, 2018 117
Short term clinical outcomes of Everolimus-eluting stents in patients with stable angina pectoris. Report Apr 30, 2018 3094
Role of intravitreal bevacizumab in management of Eale's Disease. Apr 30, 2018 3499
Procurement Of Everolimus Eluting Balloon Mounted Coronary Stent System. Apr 25, 2018 188
FDA to hold a joint committee meeting. Apr 24, 2018 101
Supply of Medicine Tab Pazopanib 400mg. Apr 23, 2018 162
Celecoxib Lowers Opioid Use Post Head & Neck Cancer Surgery; Decreased opioid use seen after head and neck cancer surgery with free tissue reconstruction. Apr 23, 2018 242
Supply Of The Exclusive Medicine Lenalidomide Capsules. Apr 15, 2018 105
Neonatal Genistein Exposure and Glucocorticoid Signaling in the Adult Mouse Uterus. Whirledge, Shannon D.; Kisanga, Edwina P.; Oakley, Robert H.; Cidlowski, John A. Report Apr 1, 2018 12057
Roche's phase III lung cancer study of Tecentriq combined with Avastin indicates clinically significant survival benefit. Mar 27, 2018 258
Roche's phase III lung cancer study of Tecentriq combined with Avastin indicates clinically significant survival benefit. Mar 27, 2018 254
Genentech Study Shows Addition of Tecentriq to Avastin /Carboplatin / Paclitaxel Extends Lifetime of People with Advanced Lung Cancer. Mar 27, 2018 399
Genentech says Phase III IMpower150 study met co-primary endpoint. Mar 26, 2018 122
Roche issues challenge to Bristol, Merck cancer drugs with Tecentriq cocktail. Mar 26, 2018 349
Dalteparin Sodium (dosage Form: Pre-filled Syringes). Mar 21, 2018 382
Supply Of Medicinal Products With The Active Substance Pazopanib. Mar 20, 2018 152
Supply Of Medicinal Products With The Active Substance Everolimus. Mar 17, 2018 174
Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab: A comparative overview. Report Feb 28, 2018 3443
Exclusive Medication Supply Lenalidomide Capsules. Feb 16, 2018 104
Roche's Tecentriq and Avastin combination decreases risk of disease worsening or death in Phase III cancer study. Feb 8, 2018 193
Roche's Tecentriq and Avastin combination decreases risk of disease worsening or death in Phase III cancer study. Feb 8, 2018 189
Roche IMmotion 151 phase 3 study saw TECENTRIQ and Avastin reduced KD risk. Feb 5, 2018 255
WET AMD DRUG DISPUTE. Feb 1, 2018 454
United States : Bevacizumab dramatically improves severe hereditary hemorrhagic telangiectasia (HHT) associated bleeding. Jan 30, 2018 739
Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. Jan 24, 2018 362
Supply Of Fn Motol - Bevacizumab 100 Mg. Jan 23, 2018 120
Bevacizumab 2015. Jan 22, 2018 119
Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. Jan 19, 2018 300
Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. Jan 19, 2018 296
Procurement Of Tacrolimus 2 Mg Tab, Tadalafil 10mg Tab, Tamoxifen Citrate 20 Mg Tab. Jan 18, 2018 144
CCGs facing legal dispute over use of cancer drug as wet AMD treatment option. Jan 9, 2018 636
CCGs facing legal dispute over use of cancer drug as wet AMD treatment option. Jan 9, 2018 640
Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, Report Jan 1, 2018 5456
Thrombotic Thrombocytopenic Purpura Associated with Pazopanib. Syed, Umer; Wahlberg, Kramer J.; Douce, Daniel R.; Sprague, Julian R. Jan 1, 2018 1493
Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features. Khan, Abdullah M.; Muzaffar, Jameel; Murthy, Hermant; Wingard, John R.; Moreb, Jan S. Jan 1, 2018 4143
Preemptive Analgesia in Total Knee Arthroplasty: Comparing the Effects of Single Dose Combining Celecoxib with Pregabalin and Repetition Dose Combining Celecoxib with Pregabalin: Double-Blind Controlled Clinical Trial. Lubis, Andri M.T.; Rawung, Rangga B.V.; Tantri, Aida R. Jan 1, 2018 4215
Modulation of Adipocyte Differentiation and Proadipogenic Gene Expression by Sulforaphane, Genistein, and Docosahexaenoic Acid as a First Step to Counteract Obesity. Valli, Veronica; Heilmann, Katharina; Danesi, Francesca; Bordoni, Alessandra; Gerhauser, Clarissa Jan 1, 2018 4491
Synthesis, Characterization, and Biodistribution of Quantum Dot-Celecoxib Conjugate in Mouse Paw Edema Model. Kalangi, Suresh K.; Swarnakar, Nitin K.; Sathyavathi, R.; Rao, D. Narayana; Jain, Sanyog; Reddanna, Jan 1, 2018 4952
Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac. Walker, Chris Jan 1, 2018 8781
Synthesis, Characterization, and Antioxidant Activities of Genistein, Biochanin A, and Their Analogues. Sherif, Salah Hamza; Gebreyohannes, BerihuTekluu Jan 1, 2018 4782
A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide. Siricilla, Mamatha; Irwin, Lydia; Ferber, Andres Jan 1, 2018 4962
Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient. Patel, Serena; Mendler, Michel H.; Valasek, Mark A.; Tsunoda, Shirley M. Jan 1, 2018 3619
An Interesting Case and Literature Review of a Coronary Stent Fracture in a Current Generation Platinum Chromium Everolimus-Eluting Stent. Aung, Sammy San Myint; Latt, Htun; Kyaw, Kyaw; Roongsritong, Chanwit Jan 1, 2018 2326
Refractive and Biometrie Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age. Chen, Yen-Chih; Chen, San-Ni; Yang, Benjamin Chi-Lan; Lee, Kun-Hsien; Chuang, Chih-Chun; Cheng, Chie Correction notice Jan 1, 2018 4240
Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery. Zuo, Lei; Zhang, Jianhong; Xu, Xun Jan 1, 2018 7550
Genistein Exposure Interferes with Pharmacokinetics of Celecoxib in SD Male Rats by UPLC-MS/MS. Zheng, Xiang; Wen, Jian; Liu, Teng-hui; Ou-yang, Qiu-Geng; Cai, Jian-ping; Zhou, Hong-yu Jan 1, 2018 3949
Lenalidomide 10mg Cap. Dec 20, 2017 136
China : JHL Submits Clinical Trial Application for Proposed Bevacizumab Biosimilar. Dec 18, 2017 142
Medicinal Products Containing Everolimus. Dec 18, 2017 105
Framework Agreement With A Single Winner By Negotiation Without Advertising For Exclusivity Of The Supply Of The Drug Lenalidomide (revlimid) (spain-oviedo: Various Medicinal Products). Dec 15, 2017 120
Roche's combination of Tecentriq and Avastin plus chemotherapy extends lung cancer patients' lives in Phase III study. Dec 11, 2017 178
Roche's combination of Tecentriq and Avastin plus chemotherapy extends lung cancer patients' lives in Phase III study. Dec 11, 2017 182
FDA Grants Genentech's Avastin Full Approval for Most Aggressive form of Brain Cancer. Dec 8, 2017 338
Tecentriq and Avastin Plus Chemotherapy Doubles PFS Compared to Avastin Plus Chemo in Advanced NSCLC. Dec 8, 2017 415
FDA grants full approval for Genentech's Avastin. Dec 5, 2017 155
Genentech Study of Tecentriq (atezolizumab) and Avastin (bevacizumab) Plus Chemotherapy Meets Primary Endpoint of PFS in Advanced Non-squamous NSCLC. Nov 27, 2017 456
Medicinal Products Containing Bevacizumab, Trastuzumab, Trastuzumab, Emtansin And Pertuzumab. Nov 24, 2017 134
Switzerland : Phase III IMpower150 study showed Roches TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer. Nov 21, 2017 243
Pnsp 21/2017 Dabrafenib, Nilotinib, Everolimus, Lapatinib, Pazopanib, Basiliximab, Mycophenolic Acid, Verteporfin And Octreotide. (spain-madrid: Pharmaceutical Products). Nov 21, 2017 115
FDA Grants Pfizer Approval of Sutent (sunitinib malate) as Adjuvant Treatment in Adults with High Risk of Recurrent RCC Following Nephrectomy. Nov 20, 2017 309
United States : Phase III IMpower150 Study Showed Genentechs Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung. Nov 20, 2017 249
Supply Of 1.01 valganciclovir 450 Mg Tab1.02 lenalidomide 25 Mg Cap1.03 hydrocortisone Enema 10x W/w1.04 tab Everolimus 10 Mg. Nov 19, 2017 130
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 260
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 256
Supply Of Tab Pazopanib 400 Mg. Nov 9, 2017 103
Opdivo (nivolumab) Shows Three-Year Survival Benefit in Advanced RCC, Reducing Risk of Death by 26% versus Everolimus in CheckMate -025 study. Nov 7, 2017 409
United States : 1818 Duration of Therapy (DOT) and Time to Next Therapy (TTNT) of Bortezomib, Carfilzomib and Ixazomib Combinations with Lenalidomide/Dexamethasone (VRd, KRd, IRd) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Clinica. Clinical report Nov 5, 2017 324
'We cannot allow NHS to be held to ransom'. Nov 1, 2017 585
Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Bukhari, Nedal Report Nov 1, 2017 1532
US FDA receives Roche's supplemental biologics license application for Avastin. Oct 30, 2017 173
US FDA receives Roche's supplemental biologics license application for Avastin. Oct 30, 2017 169
Supply Of Dalteparin (fragmin) In A Range Of Presentations To Health Boards Across Nhs Scotland. Oct 30, 2017 113
FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. Oct 27, 2017 227
FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. Oct 27, 2017 223
FDA Grants Denovo Biopharma Permission to Proceed with Clinical Trial of DB102 (Enzastaurin) in Diffuse Large B Cell Lymphoma. Oct 25, 2017 259
Supply Of Medicines For Use Of Individual Patients :nj Trastuzumab 150 Mg Nos 4 ,tab Lenalidomide 25 Mg Nos 30,inj Carfilzomib 60 Mg Nos 3,inj Fosaprepitant Dimeglumine 150 Mg. Oct 22, 2017 156
Drug Delivery - Afinitor (l01xe10), Aubagio 14 Mg (l04aa31), Avastin (l01xc07), Opdivo (l01xc17), Orencia (l04aa24). (czech Republic-prague: Antineoplastic Agentsnd). Oct 3, 2017 126
Supply Of Medical Stores To Command Hospital (cc) Lucknow : Drug Eluting Everolimus Cobalt Chromium/platinum Chromium Plateform Stent Assorted Sizes,drug Eluting Coronary Balloon With Urea Pacltaxel Coating Assorted Sizes,cto Balloon Dilatation catheter. Sep 30, 2017 144
Supply Of Tab Everolimus 5 Mg. Sep 26, 2017 103
Tab.votrient 400mg Pazopanib. Sep 19, 2017 334
Inj. Fragmin 7500 Iu. Sep 18, 2017 101
United States : FDA approves first biosimilar for the treatment of cancer. Sep 16, 2017 783
Medicinal Products Containing Pazopanib. Sep 16, 2017 122
Medicinal Products Containing Everolimus. Sep 16, 2017 125
Women denied cancer drug. Sep 15, 2017 317
Drug denied to cervical cancer patients INWALES. Sep 15, 2017 536
Tablet Pazopanib 400 Mg. Sep 15, 2017 252
Injection Containing Bevacizumab 100 Mg. Sep 15, 2017 253
Tab Pazopanib 400mg. Sep 11, 2017 120
Tab.votrient 400mg Pazopanib. Sep 11, 2017 334
P.h.no.25075) Cap Sutent (sunitinib Malate 50 Mg). Aug 30, 2017 112
Medicinal Products Containing Bevacizumab. Aug 23, 2017 123
Delivery Of Medicines (inn: Pazopanib) In 2017 To Provide Medicines And Medical Products To Certain Groups Of The Population In The Municipality Of The Resort City Of Gelendzhik In 2017. Aug 14, 2017 101
Tab.votrient 400mg Pazopanib. Aug 12, 2017 334
Tab. Everolimus 5mg In Strip Packing. Aug 3, 2017 116
(ph No.:23016) Everolimus 0.5 Mg Tab. Aug 1, 2017 109
United States : Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin1 (bevacizumab). Jul 26, 2017 223
B325 - Bevacizumab (25 Mg/Ml; 100 Mg/4 Ml; Conc. For The Infusion; Frs; B326 - Bevacizumab (25 Mg/Ml; 400 Mg/16 Ml; Conc. T1238 - Trastuzumab (600 Mg/5 Ml; Sols Inj., Sc; Frs). Jul 22, 2017 101
Health services warn over counterfeit cancer drug sold in the north. Jul 14, 2017 262
Supply Of Medicine Linagliptin 5 Mg Tab, Nandrolone Decanoate 50 Mg/ml, 1 Ml Vial Inj, Pazopanib 400 Mg Tab, Pregabalin 75 Mg + Methylcoblamine 750 Mcg tab, Sitagliptin 50mg Tab, Insulin Aspart 30%, Insulin Aspart Protamine 70% (100 Iu/ml, 3ml Vial) Inj. Jul 8, 2017 158
Botulinum Toxin Type A; Deferasirox; Emtricitabine, Tenofovir Disoproxil And Efavirenz; Entecavir; Everolimus; Peginterferon Beta-1a; Rotigotine; Sunitinib; Teriflunomide. Jul 7, 2017 124
Delivery Of Medicines - Afinitor (l01xe10) Aubagio 14mg (l04aa31), Avastin (l01xc07) opdivo (l01xc17), Orencia (l04aa24). Jul 4, 2017 131
United States : Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab. Jun 10, 2017 274
Angiogenesis and Tumor Progression Inhibition of Cyclooxygenase-2 Selective Inhibitor Celecoxib Associated with Poly (lactic-co-glycolic acid) in Tumor Cell Line Resistant to Chemotherapy/Inhibicion de Angiogenesis y Progresion Tumoral por Inhibidor Selectivo de Ciclooxigenasa-2 Celecoxib Asociado con Acido (poli lactico co-glicolico) en Linea de Celulas Tumorales Resistentes a Quimioterapia. Roa, Ignacio; Cantin, Mario; Vilos, Cristian; Rosas, Carlos; Lemus, David Jun 1, 2017 4380
Provision Of Avastin. May 19, 2017 118
Fn Motol Bevacizumab. May 11, 2017 111
United States : Avastin as effective as Eylea for treating central retinal vein occlusion. May 10, 2017 795
Inhibitors Of Protein Kinases - Everolimus. Apr 29, 2017 202
Dalteparin replacement of unfractionated heparin (UFH) for extracorporeal circuit (ECC) anticoagulation in an outpatient hemodialysis unit. Campbell, Lesley; Schneider, Maryann Brief article Apr 1, 2017 267
Medicines Containing Bevacizumab, Trastuzumab, Trastuzumab Emtansin And Pertuzumab. Mar 22, 2017 228
Celecoxib scores ok on cardiac safety: a three-drug, 10-year trial found it equivalent, or "noninferior," to ibuprofen and naproxen. Mar 1, 2017 589
IMPROVEMENT OF GROWTH PERFORMANCE AND INTESTINAL DIGESTIVE FUNCTION IN BROILER CHICKENS BY SUPPLEMENTATION OF SOY ISOFLAVONE IN CORN-SOY DIET. Report Feb 28, 2017 4228
Genentech Touts Study Data for Tecentriq, Avastin Combo in Locally Advanced or Metastatic Renal Cell Carcinoma. Feb 22, 2017 682
Tracon Pharmaceuticals' combination of TRC105 with Avastin fails to perform better than Avastin. Feb 14, 2017 199
Tracon Pharmaceuticals' combination of TRC105 with Avastin fails to perform better than Avastin. Feb 14, 2017 195
A clinical study on management of corneal neovascularisation to prevent Corneal transplant failure. Raman, Niraimozhi; Gnanaselvan, Helen Rosita Report Feb 13, 2017 2731
Celgene Receives Positive CHMP Opinion to Expand Revlimid (Lenalidomide) Indication. Jan 27, 2017 571
Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System. Bai, Yongrui; Xu, Yuejuan; Wu, Bin Report Jan 1, 2017 4331
Dietary Genistein Influences Number of Acetylcholine Receptors in Female Diabetic Jejunum. Schacht, Sydney; Masood, Faisal; Catmull, Shawn; Dolan, Robert; Altabtabaee, RussL; Grow, Wade; Nakk Report Jan 1, 2017 4960
Everolimus Implicated in Case of Severe Gastrointestinal Hemorrhage. Gonzales, Paul; Klusewitz, Seth; Marowske, Johanna; Gancayco, John; Osswald, Michael B.; Setlik, Rob Clinical report Jan 1, 2017 2028
Design and Characterization of Endostatin-Loaded Nanoparticles for In Vitro Antiangiogenesis in Squamous Cell Carcinoma. Adeyemi, Samson A.; Choonara, Yahya E.; Kumar, Pradeep; du Toit, Lisa C.; Pillay, Viness Jan 1, 2017 9552
Modeling of Tumor Growth Incorporating the Effects of Necrosis and the Effect of Bevacizumab. Drexler, Daniel Andras; Sapi, Johanna; Kovacs, Levente Report Jan 1, 2017 7532
Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes. Xu, Song; Li, Li; Li, Min; Zhang, Mengli; Ju, Mei; Chen, Xu; Gu, Heng Report Jan 1, 2017 11223
Protective Effects of Genistein against Mono-(2-ethylhexyl) Phthalate-Induced Oxidative Damage in Prepubertal Sertoli Cells. Zhang, Liandong; Gao, Ming; Zhang, Tongdian; Chong, Tie; Wang, Ziming; Zhai, Xiaoqiang; Wu, Zhizhong Report Jan 1, 2017 6668
Antiangiogenic Therapy for Diabetic Nephropathy. Tanabe, Katsuyuki; Maeshima, Yohei; Sato, Yasufumi; Wada, Jun Report Jan 1, 2017 9397
The Phytoestrogen Genistein Produces Similar Effects as 17[beta]-Estradiol on Anxiety-Like Behavior in Rats at 12 Weeks after Ovariectomy. Rodriguez-Landa, Juan Francisco; Cueto-Escobedo, Jonathan; Puga-Olguin, Abraham; Rivadeneyra-Domingu Report Jan 1, 2017 7646
Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy. Tan, Jeffrey J.; Cai, Charles L.; Shrier, Eric M.; McNally, Lois; Lazzaro, Douglas R.; Aranda, Jacob Jan 1, 2017 8750
Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes. Adrean, Sean D.; Grant, Scott; Chaili, Siyang Report Jan 1, 2017 2757
Suppression of Retinal Neovascularization by Inhibition of Galectin-1 in a Murine Model of Oxygen-Induced Retinopathy. Yang, Ning; Zhang, Wenxi; He, Tao; Xing, Yiqiao Report Jan 1, 2017 4749
Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence. Nuzzi, Raffaele; Tridico, Federico Report Jan 1, 2017 4058
Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages. Kwon, Junki; Sung, Kyung Rim Report Jan 1, 2017 5683
The CECARI Study: Everolimus (Certican[R]) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial. Van Keer, Jan; Derthoo, David; Van Caenegem, Olivier; de Pauw, Michel; Nellessen, Eric; Duerinckx, N Jan 1, 2017 5531
Evaluation of Radiosensitizing and Anti-Angiogenesis Activity of Chelidonium majus Extract in Ehrlich Ascites Carcinoma Transplanted Mice. Hassan, Asmaa Abu-Bakr; Abdel-Rafei, Mohamed Khairy; Hasan, Hesham Farouk Report Dec 31, 2016 7093
USFDA grants approval to Genentech's Avastin. Dec 8, 2016 146
USFDA grants approval to Genentech's Avastin. Dec 8, 2016 142
Amgen & Allergan partnership submits MAA to EMA for biosimilar candidate to Avastin (bevacizumab). Dec 5, 2016 256
Tab. Everolimus 5 Mg. ( 300 Tabs ). Nov 17, 2016 396
United States : Landmark study demonstrates Pfizers Celebrex (Celecoxib)has similar Cardiovascular risk as compared to prescription doses of Ibuprofen and Naproxen. Nov 15, 2016 502
Tab Pazopanib 400 Mg. Nov 4, 2016 106
Tablet/capsule Containing Everolimus 5mg. Nov 2, 2016 253
Tablet /capsule Containing Lenalidomide 10 Mg. Nov 2, 2016 254
Role of bevacizumab in the prevention of early postoperative haemorrhage after 25-gauge microincision vitrectomy surgery. Report Oct 31, 2016 2800
Tablet/capsule Containing Everolimus 10mg. Oct 26, 2016 253
Lenalidomide 10mg Tablet. Oct 25, 2016 179
Tablet Pazopanib 400 Mg. Oct 25, 2016 252
Tab Pazopanib 400 Mg. Oct 19, 2016 106
United States : New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin. Oct 12, 2016 463
KTH takes lead in administering Avastin injection service to eye patients. Oct 10, 2016 618
Cap. Sunitinib Malate 25 Mg And 12.5 Mg In Strip Packing. ( 25 Mg. - 800 Caps, 12.5 Mg. - 600 Caps ). Oct 7, 2016 400
Inj Dalteparin 7500 Iu/0.3ml.pfs. Sep 29, 2016 235
Provision Of Amgros. Sep 27, 2016 363
Supply of Dalteparin Sodium 10 Ml 100000 Iu Inj. Sep 22, 2016 139
Completion Of A Non-inclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V For Drug Dalteparin, Atc B01ab04, For The Period From 01.11.2016 Until 31.10.2018. Sep 20, 2016 197
(ph No.:03113) Celecoxib 100 Mg Cap. Sep 16, 2016 116
Celecoxib Capsules 200 Mg. Sep 12, 2016 124
Tab Everolimus 0.25 Mg ( Brand: Certican 0.25 Mg). Sep 10, 2016 214
Tab Everolimus 0.5 Mg ( Brand: Certican 0.5 Mg ). Sep 10, 2016 214
Tab Pazopanib 400mg. Sep 8, 2016 120
Provision Of Avastin And Drug Supply. Sep 1, 2016 137
Lenalidomide 10mg Tablet. Aug 31, 2016 179
Everolimus 0.75 Mg Tab, Brand- Certican. Aug 26, 2016 526
Provision Of 216-3150 Drug Dalteparin 5000ui Prefilled Syringe. Aug 24, 2016 110
Procurement Of Niv/card/0001 Everolimus Eluting Balloon Mounted Coronary Stent System (cobalt Chromium)-assorted Size. Aug 23, 2016 107
Delivery Of The Drug Inn: Everolimus (tn: Sertikan) By Decision Of The Medical Commission To Ensure That The Patient Has The Right To Receive State Social Assistance In The Village Of Kanev Kanev District Of The Krasnodar Territory In 2016. Aug 19, 2016 116
Inj Dalteparin 5000 Iu/0.2ml.pfs. Aug 8, 2016 201
Tab/cap. Everolimus 0.50mg In Strip Packing. Aug 2, 2016 201
Tab / Cap Everolimus 0.25mg In Strip Packing. Aug 2, 2016 201
Supply Of Drugs: Everolimus. Aug 2, 2016 101
Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center, Randomized, Double-blind, Double-dummy, and Parallel Controlled Trial. Zhang, Xian-Long; Yang, Jing; Yang, Liu; Liu, Jian-Guo; Cai, Xin-Yu; Fan, Wei-Ming; Yun, Xue-Qing; M Report Aug 1, 2016 3796
Tab Pazopanib 400mg. Jul 30, 2016 120
Pvms No.-010880, Tab Tamoxifen Citrate 20mg. Jul 29, 2016 118
Injection Bevacizumab 100 Mg. Jul 28, 2016 253
Eisai Receives Positive CHMP Opinion on New Indication for Anticancer Agent Lenvatinib in Combination with Everolimus for Treatment of Advanced Renal Cell Carcinoma. Jul 22, 2016 1275
Lenalidomide 10mg Tablet. Jul 22, 2016 179
Delivery Of The Drug Group Everolimus. Jul 22, 2016 121
Everolimus 0.5 mg tab. Jul 14, 2016 235
Everolimus 0.75 mg tab, brand- certican. Jul 1, 2016 513
Omalizumab 15Cma Inj iteir.l in Pazopanib -lOOmg Tab iteir.2 1980 Regorafenib -lOmg Tab iteir.3 560. Jun 18, 2016 128
Supply Of Tigycylin 50mg Inj, Pazopanib 400mg Tab, and Mycophenolate mofetil 500mg Tab. Jun 13, 2016 113
Lenalidomide 10mg tablet. Jun 11, 2016 179
?27 For Carrying Out Procurement Of Medicinal Drug Everolimus. Jun 11, 2016 277
Switzerland : Roche receives EU approval of Avastin in combination with Tarceva for patients with a specific type of advanced lung cancer. Jun 9, 2016 929
Everolimus 5mg tab. Jun 9, 2016 330
Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017 - New Market Report. Jun 7, 2016 505
Japan : Anti-Cancer Agent Avastin, Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer. May 24, 2016 290
Everolimus 0.75 mg tab in strip brand- certican. May 20, 2016 515
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. Apr 16, 2016 491
Everolimus 0.75mg tab in strip, brand-certican. Mar 22, 2016 505
Rate contract for injections - Bcmiparin, Bcndamustinc, Benzathine Pencillin, Benzathine penicillin, Benzyl Pcnicilline, Bevacizumab inj., Bevacizumab inj., BIB6B12,, Bleomycin, Bortezomib, Bortezomib. Mar 18, 2016 112
Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis. Huang, Weihuan; Liang, Yeyin; Wang, Jiajian; Li, Guoqiang; Wang, Guocai; Li, Yaolan; Chung, Hau Yin Report Mar 15, 2016 5310
Supply Of Capsule Calcitriol 0.25mcg 180, Tab Mycophenolate Mofetil 500mg 360, Tab Everolimus 0.5mg 180, Tab Everolimus 0.25mg 180, Tab Hydroxyurea 500mg. Mar 2, 2016 112
Celecoxib/PLGA Suppresses Angiogenesis and Lung Metastasis of Murine Experimental Breast Cancer/ Celecoxib/PLGA Suprime Angiogenesis y Metastasis Pulmonar de un Cancer Mamario Murino Experimental. Roa, Ignacio; Cantin, Mario; Munoz, Mariela; Rosas, Carlos; Lemus, David Mar 1, 2016 4465
Everolimus 0.75mg tab in strip , brand- certican. Feb 11, 2016 506
Framework agreement for the supply of a medicinal product containing the active substance sorafenib tosylate for na homolce hospital. Jan 13, 2016 158
Everolimus 0.75mg tab in strip. brand- certican 0.75mg. Jan 12, 2016 515
Propofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK. Zhang, Jianhai; Xia, Yunfei; Xu, Zifeng; Deng, Xiaoming Jan 1, 2016 5450
Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats. Jan 1, 2016 7224
Dalteparin sodium 5000 units pfs injection. Dec 31, 2015 106
Dalteparin sodium 5000 units pfs injection. Dec 20, 2015 106

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters